loadpatents
name:-0.04840087890625
name:-0.02512001991272
name:-0.069576978683472
Papaioannou; Nikolaos Patent Filings

Papaioannou; Nikolaos

Patent Applications and Registrations

Patent applications and USPTO patent grants for Papaioannou; Nikolaos.The latest application filed is for "heteroaryl plasma kallikrein inhibitors".

Company Profile
13.11.18
  • Papaioannou; Nikolaos - Newton MA
  • Papaioannou; Nikolaos - Boston MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Heteroaryl Plasma Kallikrein Inhibitors
App 20220298176 - Papaioannou; Nikolaos ;   et al.
2022-09-22
Heteroaryl plasma kallikrein inhibitors
Grant 11,370,803 - Papaioannou , et al. June 28, 2
2022-06-28
Inhibitors of plasma kallikrein and uses thereof
Grant 11,352,356 - Papaioannou , et al. June 7, 2
2022-06-07
Inhibitors Of Plasma Kallikrein And Uses Thereof
App 20220056028 - Travins; Jeremy ;   et al.
2022-02-24
Inhibitors of Plasma Kallikrein and uses thereof
Grant 11,168,083 - Travins , et al. November 9, 2
2021-11-09
Anti-fibrotic Compounds
App 20210246100 - Miller; Thomas ;   et al.
2021-08-12
Anti-fibrotic compounds
Grant 11,014,873 - Miller , et al. May 25, 2
2021-05-25
Heteroaryl Plasma Kallikrein Inhibitors
App 20210079022 - Papaioannou; Nikolaos ;   et al.
2021-03-18
Plasma Kallikrein Inhibitors And Uses Thereof
App 20210078999 - Papaioannou; Nikolaos ;   et al.
2021-03-18
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20200377511 - Trzupek; John David ;   et al.
2020-12-03
Inhibitors Of Plasma Kallikrein And Uses Thereof
App 20200317667 - Papaioannou; Nikolaos ;   et al.
2020-10-08
Bicyclic-fused heteroaryl or aryl compounds
Grant 10,793,579 - Trzupek , et al. October 6, 2
2020-10-06
Inhibitors of plasma kallikrein and uses thereof
Grant 10,730,874 - Papaioannou , et al.
2020-08-04
Inhibitors Of Plasma Kallikrein And Uses Thereof
App 20200239463 - Travins; Jeremy ;   et al.
2020-07-30
Anti-fibrotic Compounds
App 20200055814 - Miller; Thomas ;   et al.
2020-02-20
Inhibitors Of Plasma Kallikrein And Uses Thereof
App 20190284182 - Papaioannou; Nikolaos ;   et al.
2019-09-19
Cyclic Peptides As C5a Receptor Antagonists
App 20190270778 - Che; Ye ;   et al.
2019-09-05
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20190270751 - Trzupek; John David ;   et al.
2019-09-05
Bicyclic-fused heteroaryl or aryl compounds
Grant 10,329,302 - Trzupek , et al.
2019-06-25
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
Grant 10,316,018 - Lee , et al.
2019-06-11
Bicyclic-fused Heteroaryl Or Aryl Compounds As Irak4 Modulators
App 20190092750 - LEE; KATHERINE LIN ;   et al.
2019-03-28
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
Grant 10,174,000 - Lee , et al. J
2019-01-08
Bicyclic-fused Heteroaryl Or Aryl Compounds As Irak4 Modulators
App 20180244646 - LEE; KATHERINE LIN ;   et al.
2018-08-30
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20180127432 - Trzupek; John David ;   et al.
2018-05-10
Bicyclic-fused heteroaryl or aryl compounds
Grant 9,879,022 - Trzupek , et al. January 30, 2
2018-01-30
Novel Pyridine Pyrazinones As Bet-family Bromodomain Inhibitors
App 20160368919 - Casimiro-Garcia; Agustin ;   et al.
2016-12-22
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20160347760 - Trzupek; John David ;   et al.
2016-12-01
Bicyclic-fused heteroaryl or aryl compounds
Grant 9,458,168 - Trzupek , et al. October 4, 2
2016-10-04
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20150284405 - Trzupek; John David ;   et al.
2015-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed